Press Releases

 
Press Releases
Date Title and Summary View
Apr 5, 2017 JERSEY, Channel Islands, April 05, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 7,000,000 of its ordinary shares at a price to the public of $6.00 per share. The net proceeds to Quotient from this offering are...
Apr 4, 2017 JERSEY, Channel Islands, April 04, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of its ordinary shares. Jefferies LLC is acting as sole book-running manager and BTIG, LLC is a...
Mar 30, 2017 Antibody Detection — enhanced detection versus predicate technologiesManufacturing of Microarrays for European field trials planned to commence in early AprilMosaiQ™ instrument development completed and formal validation has commence...
Mar 23, 2017 Products are rare antisera blood typing reagents developed and manufactured by QuotientU.S. commercialization of these products will extend the range and method of reagents available in the market for antigen phenotypingEquivalent products are already...
Feb 22, 2017 JERSEY, Channel Islands, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 10:40 a.m. E...
Feb 9, 2017 JERSEY, Channel Islands, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Christopher Lindop as Chief Financial Officer.  Mr. Lindop will commence his new role on February 15, 2017. Mr. Lindop jo...
Feb 6, 2017 Performance evaluation studies for initial disease screening panel completed successfullyCompletion of European field trials expected in first half of 2017Conventional reagent business continues strong performance JERSEY, Channel...
Jan 24, 2017 JERSEY, Channel Islands, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2016 will be released after market close on Monday, February 6, 2017. ...
Jan 5, 2017 Root-cause investigation completed and corrective actions implementedPerformance evaluation study for antigen typing achieves targeted endpointsCompletion of European field trials expected in the first half of 2017 JERSEY, Channe...
Dec 21, 2016 JERSEY, Channel Islands, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company's Chairman and Chief Executive Officer, Paul Cowan, will present at the 35th annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017 at 10:00 a.m. Pacif...
Page: FirstPrevious
2
... NextLast
= add release to Briefcase